AI assistant
INSMED Inc — Director's Dealing 2025
Jul 15, 2025
30150_dirs_2025-07-15_124277d3-7dc3-46bb-a89f-fbc4a7bcf02c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2025-07-11
Reporting Person: Smith Michael Alexander (Chief Legal Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-07-11 | Common Stock | S | 748 | $96.41 | Disposed | 67327 | Direct |
| 2025-07-15 | Common Stock | S | 933 | $102.51 | Disposed | 66394 | Direct |
Footnotes
F1: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
F2: Includes 357 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F4: This is the weighted average sales price representing 933 shares sold at prices ranging from $102.37 to $102.70 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.